Oral administration of 5-methoxypsoralen affects the distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats

In Vivo

Volumn 16, Issue 3, 2002, Pages 201-213

  Lee, Yi Min ^a   Chen, Shan Fu ^a   Li, Yu Ching ^a   Lin, Song Shei ^a   Chung, Jing Gung ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 Aminofluorene; 5 Methoxypsoralen; CYPs; Ring hydroxylated metabolites

Indexed keywords

1 HYDROXY N (2 FLUORENYL)ACETAMIDE; 2 FLUORENYLAMINE; 3 HYDROXY N (2 FLUORENYL)ACETAMIDE; 5 HYDROXY N (2 FLUORENYL)ACETAMIDE; 7 HYDROXY N (2 FLUORENYL)ACETAMIDE; 8 HYDROXY N (2 FLUORENYL)ACETAMIDE; 9 HYDROXY N (2 FLUORENYL)ACETAMIDE; BERGAPTEN; CARCINOGEN; CYTOCHROME P450 2A6; CYTOCHROME P450 2B1; N (2 FLUORENYL)ACETAMIDE; UNCLASSIFIED DRUG; 2-AMINOFLUORENE; 5-METHOXYPSORALEN; DRUG DERIVATIVE; FLUORENE DERIVATIVE; METHOXSALEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; BLOOD ANALYSIS; CARCINOGEN TESTING; COLON; CONTROLLED STUDY; CYTOSOL; DEFECATION; DRUG EFFECT; DRUG METABOLISM; DRUG TRANSFORMATION; DRUG TRANSPORT; FECES ANALYSIS; FECES LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; KIDNEY; LIVER; MALE; METABOLITE; NONHUMAN; RAT; STOMACH; STOMACH INTUBATION; TARGET ORGAN; TISSUE DISTRIBUTION; URINALYSIS; URINARY EXCRETION; URINE LEVEL; ANIMAL; DRUG INTERACTION; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; FLUORENES; MALE; METHOXSALEN; RATS; TISSUE DISTRIBUTION;

EID: 0035988716     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Paeonol promotes arylamine N-acetyltransferase activity in rat liver tumour cells
2. Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype
3. New insights into carcinogenesis of the classical model arylamine 2-acetylaininofluorene
4. Effects of Ibuprofen on arylamine N-acetyltransferase activity in human colon tumor cells
5. Induction of sulfamethazine acetylation by hydrocortisone in the rabbit
6. Immunological evidence for N-acetyltransferase isozymes in the rabbit
7. Drug metabolizing N-acetyltransferase activity in human cell lines
8. Evidence that arylhydroxamic acid N,O-acyltransferase and the genetically polymorphic N-acetyltransferase are properties of the same enzyme in rabbit liver
9. Biochemical characterization of genetically variant aromatic amine N-acetyltransferase in A/J and C57BL/6J mice
10. Acetylator genotype and arylamine-induced carcinogenesis
11. Effect of sulindac on arylamine N-acetyltransferase activity in human colon tumour cells
12. Effects of aspirin on arylamine N-acetyltransferase activity and DNA adducts in human bladder tumour cells
13. Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low-level exposure to 2-acetylaminofluorene
14. Deactylation to 2-aminofluorene as a major initial reaction in the microsomal metabolism of 2-acetylaminofluorene to mutagenic product in preparations from rabbit lung and liver
15. Modulation of the embryotoxicity and cytotoxicity elicited by 7-Hydroxy-2-acetylamino-fluorene and acetaminophen via deacetylation
16. DNA ligase activities during hepatocarcinogenesis induced by N-2acetylaminofluorene
17. Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites
18. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavincontaining and cytochrome P-450 monooxygenases
19. A comparison of the inhibition of deacetylase in primary cultures of rat and human hepatocytes effecting metabolism and DNA-binding of 2-acetylaminofluorene
20. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylamino-fluorene in the inbred hamster
21. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene
22. Metabolism of 2-acetylaminofluorene. I. Metabolism in vitro of 2-acetylaminofluorene and 2-acetylaminofluorene-9-one by hepatic enzymes
23. Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylarninofluorene
24. Metabolism of 2-acetylaminofluorene by hepatocytes isolated from rainbow trout
25. Inhibition of sulfotransferase in primary cultures of human hepatocytes affecting metabolism and binding of 2-acetylaminofluorene
26. Chromatographic separation of some metabolites of the carcinogen N-2-fluorenylacetamide
27. Mutagenic compounds in an extract from Rutae Herba (Ruta graveolens L.). II. UV-A mediated mutagenicity in the green alga Chamydomonas, reinhardtii by furoquinoline alkaloids and furocoumarins present in a commercial tincture from Rutae Herba
28. Host plant resistance and linear furanocoumarin content of Apium accessions
29. DNA damage in UV-irradiated human skin in vivo: Automated direct measurement by image analysis (tymine dimers) compared with indirect measurement (unscheduled DNA synthesis) and protection by 5-methoxypsoralen
30. High-performance liquid chromatographic determination of citropten and bergapten in suction blister fluid after solar product application in humans
31. Anti-tumor-promotion by principles obtained from Angelica keiskei
32. Studies of the active constituents of the Chinese drug "duhuo" Angelica pubescents
33. Effects of active compounds isolated from Angelica shikokiana on lipid metabolism in fat cell
34. 5-methoxypsoralen as a specific stimulating agent of melatonin secretion in humans
35. Psoralen-containing sunscreen is tumorigenic in hairless mice
36. The effects of berbapten and sunlight on cutaneous pigmentation
37. Photoprotection by furocoumarin-induced melanogenesis against DNA photodamage in mouse epidermis in vivo
38. Methoxypsoralen phototherapy of transitional cell carcinoma
39. Bath-5-methoxypsoralen-UVA therapy for psoriasis
40. Psoralen-containing sunscreen induces phototoxicity and epidermal ornithine decarboxylase activity
41. Psoralen-induced growth inhibition in Wistar rats
42. Mechanism-based inactivation of P450 2A6 by furanocoumarins
43. Mechanism-based inactivation of cytochrome P450 2BI by 8-methoxypsoralen and several other furanocoumarins
44. Searches for the ultimate chemical carcinogens and their reaction with cellular macromolecules
45. Cytochrome P-450-dependent biotransformation of 2-acetylaminofluorene in cell-free preparations of human embryonic hepatic, adrenal, renal, pulmonary, and cardiac tissues
46. Further metabolism of 2-formylaminofluorene, a metabolite of 2-aminofluorene, in rats
47. Solvolysis and metabolic degradation by rat liver of the ultimate carcinogen, N-sulfonory-2-acetylaminofluorene
48. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer
49. NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese
50. Comparison between DNA adduct formation and tumorigenesis in livers and bladders of mice chronically fed 2-acetylamino-fluorene
51. Gas chromatographic-mass spectrometric study of deacetylation and oxidation of 2-acetylaminofluorene by rat liver epithelial cell lines upon cocarcinogen induction
52. Effects of harman and norharman on the metabolism and genotoxicity of 2-acetylaminofluorene in cultured rat hepatocytes
53. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450